WATERTOWN, Mass.--(BUSINESS WIRE)-- Forma Therapeutics Holdings, Inc. (Nasdaq: FMTX), a clinical-stage biopharmaceutical company focused on rare hematologic diseases and cancers, today announced the ...
WATERTOWN, Mass. & OXFORD, England--(BUSINESS WIRE)--FORMA Therapeutics and the University of Oxford announced today they have entered into a collaboration and license agreement to identify, validate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results